arginine vasopressin has been researched along with (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellemère, G; Jégou, S; Morain, P; Vaudry, H | 1 |
1 other study(ies) available for arginine vasopressin and (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole
| Article | Year |
|---|---|
Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain.
Topics: Amygdala; Animals; Arginine Vasopressin; Brain; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; In Vitro Techniques; Indoles; Male; Nootropic Agents; Protease Inhibitors; Rats; Rats, Wistar; Serine Endopeptidases; Thiazoles; Thiazolidines; Thyrotropin-Releasing Hormone | 2005 |